AREV Nutrition Sciences CEO: We’re Ready to Go Into Massive Product Launch

Share on Linkedin

AREV Nutrition Sciences Inc. (CNSX:ARV) has a line of nutraceutical products and is planning to expand into the cannabinoids market


In this interview with SmallCapPower at the recent Formula 1 Capital Conference in Montreal, AREV Nutrition Sciences Inc (CSE: ARV) CEO Stephane Maher talks about his Company’s line of nutraceutical products and outlines how AREV is planning to expand into the cannabinoids market. Watch our video interview to find out more.

Disclosure: Neither any of the principals at Small Cap Power, nor their family members, own shares in any of the companies mentioned above.

The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below: